Design Therapeutics
DSGN
DSGN
96 hedge funds and large institutions have $223M invested in Design Therapeutics in 2023 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 23 increasing their positions, 27 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 27
46% less capital invested
Capital invested by funds: $413M → $223M (-$189M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
96
Holding in Top 10
1
Calls
$1.09M
Puts
$283K
Top Buyers
| 1 | +$7.08M | |
| 2 | +$2.09M | |
| 3 | +$1.61M | |
| 4 |
Millennium Management
New York
|
+$1.58M |
| 5 |
Jane Street
New York
|
+$1.17M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$9.08M | |
| 3 | -$2.5M | |
| 4 |
BlackRock
New York
|
-$1.86M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.61M |